Next-generation cancer tests are being developed here in Houston, and the HBJ pulled back the curtain on how one partnership ...

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites ...

Advances in next-generation sequencing (NGS) and synthetic DNA technologies are reshaping oncology research by enabling earlier cancer detection, more accurate biomarker discovery, and sensitive ...

Anderson inks partnership powered by AI cancer diagnostics to develop genomic tools that improve cancer diagnosis and treatment decisions.

Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma A retrospective cohort study was conducted at Chris ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...

Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...